comparison of glp-1 agonists Treatment with Receptor GLP-1-based therapies: current knowledge of
Description
E., Hayes, M

Preclinical studies in diet-induced obesity rodent models are ongoing to evaluate its efficacy, safety, and tolerability as a potential therapy for type 2 diabetes and obesity

Not as powerful as tirzepatide or retatrutide in head-to-head data

Do GLP-1 receptor agonists have cardiovascular benefits

A series of rationally designed modifications included the interchange of specific GIP-derived amino acids, the addition of the C-terminally extended residues from the reptilian GLP-1R agonist, exendin-4, and select non-canonical amino acids at position 2 and 20

& He, C
